4th Quarter - Report
VIATRIS INC. for VIATRIS INC
Firm
Client
Income
—
Expenses
$410,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 3627/S. 1884, School Access to Emergency Epinephrine Act; S. 3187, Food and Drug Administration Safety and Innovation Act (FDASIA), Title 3, Generic Drug User Fee Amendment (GDUFA), Title 4, Fees Relating to Biosimilar Biological Products; Pharmaceutical Distribution Supply Chain; HIV/AIDS; Patent Settlements; Biosimilars; Electronic Distribution of Labeling of Prescription Drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL LUBOWITZ | — |
| LARA RAMSBURG | — |
| NIMISH SHAH New | — |
Copyright/Patent/Trademark CPT
Patent settlements
| Lobbyist | Covered position, as disclosed |
|---|---|
| LARA RAMSBURG | — |
| NIMISH SHAH New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.